Ana M. Tari
- Molecular Biology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Genetics top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Gabriel Lopez‐BeresteinAnn‐Marie SimeoneMusaffe TunaRené Nieves-AliceaBülent ÖzpolatMien‐Chie HungYasuko KondoPablo Zapata‐Benavides
- Topics
- Retinoids in leukemia and cellular processes (14 papers)HER2/EGFR in Cancer Research (12 papers)Estrogen and related hormone effects (12 papers)
- Partner nations
- United StatesMexicoCanada
In The Last Decade
Ana M. Tari
65 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 111
- Molecular Biology 1.7k
- Oncology 708
- Cancer Research 367
- Genetics 256
- Radiology, Nuclear Medicine and Imaging 238
Countries citing papers authored by Ana M. Tari
This map shows the geographic impact of Ana M. Tari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana M. Tari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana M. Tari more than expected).
Fields of papers citing papers by Ana M. Tari
This network shows the impact of papers produced by Ana M. Tari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana M. Tari. The network helps show where Ana M. Tari may publish in the future.
Co-authorship network of co-authors of Ana M. Tari
This figure shows the co-authorship network connecting the top 25 collaborators of Ana M. Tari. A scholar is included among the top collaborators of Ana M. Tari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana M. Tari. Ana M. Tari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 140 | |
| 3 | 48 | |
| 4 | 215 | |
| 5 | 32 | |
| 6 | 7 | |
| 7 | 39 | |
| 8 | 101 | |
| 9 | 21 | |
| 10 | 24 | |
| 11 | 5 | |
| 12 | 123 | |
| 13 | 91 | |
| 14 | The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002. | 37 |
| 15 | 18 | |
| 16 | 44 | |
| 17 | 11 | |
| 18 | 60 | |
| 19 | 22 | |
| 20 | Antisense oligonucleotides and carriers for gene therapy | 4 |
About Ana M. Tari
Ana M. Tari is a scholar working on Oncology, Hematology and Molecular Biology, having authored 65 papers that have together received 2.6k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (14 papers), HER2/EGFR in Cancer Research (12 papers) and Estrogen and related hormone effects (12 papers). The work is most often cited by research in Oncology (708 citations), Molecular Biology (1.7k citations) and Immunology and Allergy (151 citations). Ana M. Tari has collaborated with scholars based in United States, Mexico and Canada. Frequent co-authors include Gabriel Lopez‐Berestein, Ann‐Marie Simeone, Musaffe Tuna, René Nieves-Alicea, Bülent Özpolat, Mien‐Chie Hung, Yasuko Kondo, Pablo Zapata‐Benavides, Seiji Kondo and Michael Andreeff. Their work appears in journals such as Journal of Biological Chemistry, Blood and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.